BioLineRx (BLRX) Cash & Current Investments (2010 - 2026)
BioLineRx (BLRX) posted Cash & Current Investments of $13.08 million for the quarter ended Jun 30, 2026, compared with -$17.63 million a year earlier and down 24.6% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Cash & Current Investments (2010 - 2026) Analysis & Trends
As of Dec 31, 2025, BioLineRx's Cash & Current Investments came in at $20.88 million, up 6.7% from the prior year.
- In prior years, BioLineRx's Cash & Current Investments was $19.56 million in the year ended Dec 31, 2024, -$43.33 million in the year ended Dec 31, 2023, -$33.41 million in the year ended Dec 31, 2022 and -$65.01 million in the year ended Dec 31, 2021.
- Quarterly Cash & Current Investments has run from a low of -$65.01 million in the quarter ended Dec 31, 2021 to a high of $57.26 million in the quarter ended Sep 30, 2022 over five years.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was the quarter ended Jun 30, 2024, with growth of 22.1%; the weakest was the quarter ended Sep 30, 2023, with a decline of 54.7%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $17.35 million (quarter ended Mar 31, 2026), $20.88 million (quarter ended Dec 31, 2025) and $25.21 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | BioLineRx | 8.53 Mn | -67.99 Mn | 235,000.00 | 13.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.08 Mn |
| Mar 31, 2026 | 17.35 Mn |
| Dec 31, 2025 | 20.88 Mn |
| Sep 30, 2025 | 25.21 Mn |
| Jun 30, 2025 | 28.16 Mn |
| Mar 31, 2025 | 26.37 Mn |
| Dec 31, 2024 | 19.56 Mn |
| Sep 30, 2024 | 29.17 Mn |
| Jun 30, 2024 | 40.06 Mn |
| Mar 31, 2024 | 28.17 Mn |
| Dec 31, 2023 | 42.99 Mn |
| Sep 30, 2023 | 25.97 Mn |
| Jun 30, 2023 | 32.82 Mn |
| Mar 31, 2023 | 43.29 Mn |
| Dec 31, 2022 | 51.08 Mn |
| Sep 30, 2022 | 57.26 Mn |
| Jun 30, 2022 | 43.15 Mn |
| Mar 31, 2022 | 50.59 Mn |
| Dec 31, 2021 | 57.14 Mn |
| Sep 30, 2021 | 62.21 Mn |
API Access
BioLineRx Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();